The Pharma Data
NOVEMBER 15, 2020
Lead Pharma is headquartered at Pivot Park, the biopharmaceutical life sciences campus in Oss, the Netherlands. Contact: Media Inquiries: LifeSpring Life Sciences Communication, Amsterdam Leon Melens Tel.: +31 . OSS, Netherlands , Nov. For more information visit: www.leadpharma.com.
XTalks
MAY 20, 2022
Depending on the type of field or company, you can pursue clinical scientist jobs with a major in biology, medicine, medical technology, chemistry, immunology and other related life science and pre-medical degrees. Below is a brief preview from the National Health Services’ list of healthcare science fields: Vascular Science.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
The Pharma Data
MARCH 2, 2021
Boehringer Ingelheim and Gubra today announced a new research and licensing agreement focused on the identification and validation of targets and innovative peptide compounds for the treatment of obesity. billion euros in R&D drives innovation, enabling the next generation of medicines that save lives and improve quality of life.
XTalks
DECEMBER 13, 2023
This impressive growth can be attributed to Fulgent’s distinctive chemistries and advanced proprietary bioinformatics pipeline, which have been instrumental in fueling the company’s rapid advancement in recent years. It is now progressing towards the submission of a Biologics License Application (BLA) by the end of 2023.
pharmaphorum
MAY 27, 2022
data processing systems that support bioinformatics modelling) and digital record systems (e.g. Underrepresentation is multifactorial, so concerted efforts from life science companies are required to address inequitable healthcare. video consultations), health data analytics (e.g.
XTalks
SEPTEMBER 5, 2023
Investigation of the possibility of VAED is crucial during clinical trials for decision-making on vaccine licensing by regulatory agencies. This system integrates mathematical modeling, biological science and bioinformatics and it could identify, report and mitigate new drugs and vaccines faster.
Drug Discovery World
NOVEMBER 9, 2023
Peter O’Callaghan, PhD, Head of Expression System Sciences, Biologics and Licensing, Lonza, on: ‘Solve bispecific heavy-light chain mispairing with bYlok technology’. Business Partnership Manager, Azenta Life Sciences, on: ‘Innovative antibody discovery workflow leveraging artificial intelligence to prioritise leads’.
Expert insights. Personalized for you.
52 
Let's personalize your content